Nature's Sunshine Products Inc(NATR) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | 13.57 | EPS (ttm) | 1 | Insider Own | 5.72% | Shs Outstand | 17.6M | Perf Week | -3.88% |
| Market Cap | 0.24B | Forward P/E | 11.07 | EPS next Y | 13.89% | Insider Trans | 9.44% | Shs Float | 16.6M | Perf Month | -14.88% |
| Enterprise Value | 0.18B | PEG | - | EPS next Q | 0.27 | Inst Own | 90.91% | Short Float | 3.28% | Perf Quarter | -33.51% |
| Income | 0.02B | P/S | 0.49 | EPS this Y | -14.29% | Inst Trans | 2.96% | Short Ratio | 3.28 | Perf Half Y | -45.03% |
| Sales | 0.49B | P/B | 1.42 | EPS next 5Y | -1.07% | ROA | 7.03% | Short Interest | 0.54M | Perf YTD | -36.93% |
| Book/sh | 9.61 | P/C | 2.9 | EPS past 3/5Y | - -0.22% | ROE | 11.07% | 52W High | -51.63% ($28.14) | Perf Year | -20.64% |
| Cash/sh | 4.69 | P/FCF | 13.24 | Sales past 3/5Y | 4.4% 4.5% | ROIC | 9.71% | 52W Low | 4.91% ($12.97) | Perf 3Y | -17.42% |
| Dividend Est. | - | EV/EBITDA | 4.18 | EPS Y/Y TTM | 34.53% | Gross Margin | 70.45% | Volatility(W/M) | 2.73% 3.26% | Perf 5Y | -16.5% |
| Dividend TTM | - | EV/Sales | 0.36 | Sales Y/Y TTM | 6.77% | Oper. Margin | 5.96% | ATR (14) | 0.56 | Perf 10Y | -2.83% |
| Dividend Ex-Date | 2021/3/26 | Quick Ratio | 1.55 | EPS Q/Q | -31.4% | Profit Margin | 3.68% | RSI (14) | 26.26 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.6 | Sales Q/Q | 1.95% | SMA20 | -4.49% ($14.25) | Beta | 0.8 | Target Price | $30.5 |
| Payout | - | Debt/Eq | 0.13 | Earnings | 2026/8/6 | SMA50 | -23.69% ($17.84) | Rel Volume | 0.84 | Prev Close | $13.66 |
| Employees | 806 | LT Debt/Eq | 0.1 | EPS/Sales Surpr. | -22.22% -5.43% | SMA200 | -38.61% ($22.17) | Avg Volume(3M) | 0.17M | Price | $13.61 |
| IPO | 1980/3/17 | Option/Short | Yes/Yes | Trades | 2279 | Volume | 138,874 | Change | -0.37% |
Company
NATR is a Consumer Defensive sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🌿 Established in 1972, it is a global health functional food and personal care manufacturing and distribution company. Headquartered in Utah, USA, it supplies nutritional supplements, herbal products, immunity and weight management products across more than 40 countries through direct sales and a digital subscription economy platform, building a stable health and wellness brand value.
Over the past 1 year, on the lower side
52% below its 1-year high.
NATR makes money exceptionally well
5.96% of revenue is kept as operating profit.
Tap to view numbers
Growth has stalled
Earnings are expected to grow by -14.3% this year.
Tap to view numbers
The stock looks undervalued
Trading at 13.6 times earnings.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by -17.4% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 90.9%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
SAWS 0.01%
FDM 0.00%
FSML 0.00%
SQLV 0.00%
BFOR 0.00%It ranks #4 in the industry
Based on market cap of $239M.
NATR $239M PER 13.6
KHC $29B PER -
GIS $19B PER -
MKC $14B PER 8.5
FAQ
What kind of company is NATR?
NATR belongs to the Consumer Defensive sector and operates in the Packaged Foods industry.
What is the market cap of NATR?
The market cap of NATR is approximately $239M, ranking 3,952 within its sector.
What is the P/E ratio of NATR?
NATR has a P/E ratio of approximately 13.6x, which can be used to assess its valuation relative to the Consumer Defensive sector average.
What is the 52-week high and low for NATR?
NATR has recorded a 52-week high of $28.14 and a low of $12.97.
